TrialBJU international2026

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial.

Nikita Sushentsev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.